Login to Your Account



Exelixis aims to expand pipeline, keep cabo momentum going in 2017

By Jennifer Boggs
Managing Editor

Wednesday, January 11, 2017

SAN FRANCISCO – Exelixis Inc. was 2015's top biopharma gainer on Wall Street and one of the top firms in 2016, according to BioWorld Insight.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription